Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant non-syndromic intellectual disability in which the cause of the disease is a mutation in the EEF1A2 gene.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Ataxia, Severe intellectual disability, Aggressive behavior |
Head and neck | 4 | Tented upper lip vermilion, High palate, Microcephaly |
Muscles | 2 | Generalized neonatal hypotonia, Brain shrinkage (cerebral atrophy) |
Pregnancy and birth | 1 | Generalized neonatal hypotonia |
EEF1A2 encodes eukaryotic translation elongation factor 1 alpha 2 (463 aa). Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis. Highest expression in Muscle Skeletal (2,328 TPM) and Brain Cerebellar Hemisphere (972.2 TPM).
Intellectual disability, autosomal dominant 38 is associated with mutations in the EEF1A2 gene on chromosome 20.
EEF1A2 is classified as a druggable target with score 26.1.
Genetic testing for EEF1A2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, autosomal dominant 38 has been reported in the published literature.
Phenotype severity distribution: 14 always present features, 13 common features.
No clinical trials have been registered for intellectual disability, autosomal dominant 38.
16 publications have been identified in PubMed for intellectual disability, autosomal dominant 38. Research spans Review / Meta-Analysis (40%), Epidemiology / Natural History (33%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 40% |
Disease patterns and progression | 5 | 33% |
Patient case studies | 3 | 20% |
Testing and diagnosis research | 1 | 7% |
Ates K (2026). [PMID: 42204957](https://pubmed.ncbi.nlm.nih.gov/42204957/). *Dev Neurobiol*. [Review / Meta-Analysis]
Wang Z (2026). [PMID: 41916888](https://pubmed.ncbi.nlm.nih.gov/41916888/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Review / Meta-Analysis]
Li M (2026). [PMID: 41710014](https://pubmed.ncbi.nlm.nih.gov/41710014/). *Frontiers in pediatrics*. [Review / Meta-Analysis]
van der Leij M (2026). [PMID: 41680088](https://pubmed.ncbi.nlm.nih.gov/41680088/). *American journal of medical genetics. Part A*. [Review / Meta-Analysis]
Hossain WA (2025). [PMID: 39941075](https://pubmed.ncbi.nlm.nih.gov/39941075/). *International journal of molecular sciences*. [Review / Meta-Analysis]
Pizzol A (2025). [PMID: 39494522](https://pubmed.ncbi.nlm.nih.gov/39494522/). *American journal of medical genetics. Part A*. [Epidemiology / Natural History]
Gatsis A (2025). [PMID: 39911174](https://pubmed.ncbi.nlm.nih.gov/39911174/). *Molecular syndromology*. [Case Report / Case Series]
Kong JY (2025). [PMID: 40050103](https://pubmed.ncbi.nlm.nih.gov/40050103/). *[Zhonghua yan ke za zhi] Chinese journal of ophthalmology*. [Case Report / Case Series]
Osman MF (2024). [PMID: 39882213](https://pubmed.ncbi.nlm.nih.gov/39882213/). *Frontiers in pediatrics*. [Epidemiology / Natural History]
Majjigudda RA (2024). [PMID: 39600756](https://pubmed.ncbi.nlm.nih.gov/39600756/). *Cureus*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center